|1.||Meeves, Suzanne: 7 articles (02/2007 - 07/2002)|
|2.||Kittner, Barbara: 5 articles (07/2008 - 12/2004)|
|3.||Georges, George: 5 articles (10/2006 - 10/2003)|
|4.||Bachert, Claus: 4 articles (11/2011 - 04/2003)|
|5.||Bartra, J: 4 articles (01/2011 - 01/2002)|
|6.||Lutz, Cheryl: 4 articles (10/2006 - 07/2002)|
|7.||Berkowitz, Robert B: 4 articles (10/2006 - 07/2002)|
|8.||Liao, Yuning: 4 articles (10/2006 - 10/2003)|
|9.||Lipworth, B J: 4 articles (04/2004 - 01/2002)|
|10.||Miyachi, Yoshiki: 3 articles (01/2015 - 12/2012)|
|1.||Seasonal Allergic Rhinitis (Hay Fever)
10/01/1999 - "Once-daily fexofenadine HCl, 120 or 180 mg, significantly improved patient-reported quality of life and reduced performance impairment in work and daily activities due to seasonal allergic rhinitis symptoms compared with placebo."
11/01/1997 - "Fexofenadine HCl is both effective and safe for the treatment of ragweed seasonal allergic rhinitis. "
01/01/2011 - "Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials."
06/01/2004 - "To evaluate the safety and efficacy of fexofenadine in children with seasonal allergic rhinitis, data were pooled from three, double-blind, randomized, placebo-controlled, parallel-group, 2-week trials in children (6-11 year) with seasonal allergic rhinitis. "
06/01/2004 - "Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies."
11/01/2012 - "Those with significant improvement of urticaria activity score under fexofenadine at 180 mg were included in the CIU group. "
02/01/1998 - "Fexofenadine 180 or 240mg once daily was significantly more effective than placebo in patients with chronic idiopathic urticaria. "
01/01/2008 - "These studies also support the contention that fexofenadine is effective for the treatment of allergic rhinits and chronic idiopathic urticaria."
04/10/2002 - "Fexofenadine 180 mg is a new antihistamine that is effective in the treatment of chronic urticaria and that has a profile of side effects similar to placebo."
02/01/2000 - "Although no comparative data with other H1 antagonists exist, fexofenadine 180 mg once daily was effective in reducing the symptoms of chronic idiopathic urticaria for up to 6 weeks. "
12/01/2005 - "Fexofenadine 30 mg bid is effective in reducing the total symptom score of allergic rhinitis including blocked nose and is generally well tolerated. "
10/01/2005 - "Fexofenadine is effective for the treatment of allergic rhinitis. "
12/01/2002 - "Clinical studies have documented the efficacy of fexofenadine in the treatment of allergic rhinitis. "
02/01/2006 - "Efficacy of fexofenadine in the prophylactic control of cat allergen-induced allergic rhinitis."
01/01/2009 - "This study demonstrates that fexofenadine is able to mediate significant changes in different nasal lavage markers from patients with intermittent allergic rhinitis. "
02/01/2006 - "Our results suggest that fexofenadine can be beneficial in the daily management of patients with itching due to eczematous disease."
06/01/2005 - "Patients administered fexofenadine (n = 163) experienced significantly greater improvements in MNW and pruritus severity scores compared with the placebo group (n = 92) (P < .001 for both). "
06/01/2003 - "Compared with placebo, fexofenadine significantly improved both diurnal (P = 0.0001) and nocturnal pruritus (P = 0.013). "
06/01/2003 - "Fexofenadine (n = 201) significantly decreased the severity of pruritus compared with placebo (n = 199) (mean change in score -0.75 (unadjusted 95% confidence interval [-0.88, -0.62]) vs. -0.5 [-0.62, -0.38], respectively; P = 0.0005). "
11/01/1999 - "Two subjects developed mild itching, which cleared up after receiving Allegra; the third subject did not respond to the treatment."
03/01/2009 - "FFNS once daily was more effective than fexofenadine and placebo with respect to nighttime sleep disturbance caused by seasonal allergy symptoms."
11/01/2001 - "The present pilot study aimed to evaluate the therapeutic effect exerted by fexofenadine in patients with PAR due to mite allergy. "
05/01/1998 - "Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies."
12/01/1997 - "Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit."
12/01/2009 - "Assessment of the antiobstructive effect of fexofenadine on nasal allergy challenge in patients with seasonal allergic rhinitis."
|9.||Cromolyn Sodium (Cromoglicic Acid)
|3.||Phototherapy (Light Therapy)